Mingxia Feng

Harnessing Type I and Type III CRISPR-Cas systems for genome editing

Yingjun Li, Saifu Pan, Yan Zhang et al. · Nucleic Acids Research · 2015 · 231 citations · Full text

Engineering, Cell Modification, Crispr-cas Systems +14

An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference

Wenfang Peng, Mingxia Feng, Xu Feng et al. · Nucleic Acids Research · 2014 · 154 citations · Full text

Dna Interference, Engineering, Crispr-cas Systems +15

Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy

Yubo Wang, Nong Yang, Yongchang Zhang et al. · Journal of Thoracic Oncology · 2020 · 100 citations

Cis-c797s Triple Mutations, Cetuximab Combination Therapy, Medicine +9

Structure of Csx1-cOA4 complex reveals the basis of RNA decay in Type III-B CRISPR-Cas

Rafael Molina, Stefano Stella, Mingxia Feng et al. · Nature Communications · 2019 · 90 citations · Full text

A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction

Wenyuan Han, Yingjun Li, Ling Deng et al. · Nucleic Acids Research · 2016 · 87 citations · Full text